IL-15 constrains mast cell–dependent antibacterial defenses by suppressing chymase activities

[1]  J. Crawford,et al.  Setting the stage. , 2021, The New England journal of medicine.

[2]  F. Liew,et al.  IL-12, but Not IL-18, Is Critical to Neutrophil Activation and Resistance to Polymicrobial Sepsis Induced by Cecal Ligation and Puncture1 , 2006, The Journal of Immunology.

[3]  H. Schild,et al.  Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27 , 2006, The Journal of experimental medicine.

[4]  R. Paus,et al.  IL-15/IL-15 receptor biology: a guided tour through an expanding universe. , 2006, Cytokine & growth factor reviews.

[5]  R. Paus,et al.  The interleukin‐15/interleukin‐15 receptor system as a model for juxtacrine and reverse signaling , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[6]  B. Lindner,et al.  Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. , 2006, Blood.

[7]  M. Sitkovsky,et al.  Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.

[8]  Wei Zhao,et al.  Cytokine Production by Skin-Derived Mast Cells: Endogenous Proteases Are Responsible for Degradation of Cytokines 1 , 2005, The Journal of Immunology.

[9]  M. Maurer,et al.  TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. , 2005, Blood.

[10]  L. Hellman,et al.  Loss of Histochemical Identity in Mast Cells Lacking Carboxypeptidase A , 2005, Molecular and Cellular Biology.

[11]  C. Cetrulo,et al.  Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor1 , 2005, The Journal of Immunology.

[12]  Narayanasami Sukumar,et al.  A Novel, Potent Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase , 2005, Journal of Biological Chemistry.

[13]  Wei Zhao,et al.  Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. , 2005, Journal of immunology.

[14]  H. Sarau,et al.  Angiotensin II Induces Neutrophil Accumulation In Vivo Through Generation and Release of CXC Chemokines , 2004, Circulation.

[15]  J. Wedemeyer,et al.  Mast cells promote homeostasis by limiting endothelin-1-induced toxicity , 2004, Nature.

[16]  J. Marshall.  Mast-cell responses to pathogens , 2004, Nature Reviews Immunology.

[17]  C. Hack,et al.  Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with beta-tryptase monomers. , 2004, Blood.

[18]  K. Kandere-Grzybowska,et al.  IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells1 , 2003, The Journal of Immunology.

[19]  R. Rottapel,et al.  Suppressor of Cytokine Signaling 1 Regulates an Endogenous Inhibitor of a Mast Cell Protease* , 2003, Journal of Biological Chemistry.

[20]  R. Paus,et al.  Mast Cells Express Novel Functional IL-15 Receptor α Isoforms1 , 2003, The Journal of Immunology.

[21]  Peter A. Ward,et al.  Novel strategies for the treatment of sepsis , 2003, Nature Medicine.

[22]  Y. Nimura,et al.  Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. , 2003, The Journal of infectious diseases.

[23]  M. Caligiuri,et al.  What does it take to make a natural killer? , 2003, Nature Reviews Immunology.

[24]  A. Vitiello,et al.  Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide 1 , 2003, The Journal of Immunology.

[25]  Jonathan Cohen.  The immunopathogenesis of sepsis , 2002, Nature.

[26]  A. Fukamizu,et al.  Rodent α‐chymases are elastase‐like proteases , 2002 .

[27]  M. Arock,et al.  The role of mast cells in host defense and their subversion by bacterial pathogens. , 2002, Trends in immunology.

[28]  T. Selwood,et al.  Evidence for diversity of substrate specificity among members of the chymase family of serine proteases , 2002, FEBS letters.

[29]  J. Keski‐Oja,et al.  Activation of paracrine TGF‐β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  S. Peltz,et al.  The cap-to-tail guide to mRNA turnover , 2001, Nature Reviews Molecular Cell Biology.

[31]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[32]  R. Strieter,et al.  Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1. , 2000, The American journal of pathology.

[33]  S. Abraham,et al.  Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis , 2000, Journal of leukocyte biology.

[34]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[35]  R. Bucala,et al.  Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.

[36]  H. Miller,et al.  A novel function for transforming growth factor-beta1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1. , 1999, Blood.

[37]  G. Kollias,et al.  The c-kit Ligand, Stem Cell Factor, Can Enhance Innate Immunity Through Effects on Mast Cells , 1998, The Journal of experimental medicine.

[38]  T. Dassopoulos,et al.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.

[39]  A. Sali,et al.  Regulation and Function of Mast Cell Proteases in Inflammation , 1998, Journal of Clinical Immunology.

[40]  R. Paus,et al.  Interleukin-15 protects from lethal apoptosis in vivo , 1997, Nature Medicine.

[41]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[42]  B. Echtenacher,et al.  Critical protective role of mast cells in a model of acute septic peritonitis , 1996, Nature.

[43]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[44]  K. Austen,et al.  Post-transcriptional Regulation of Chymase Expression in Mast Cells , 1996, The Journal of Biological Chemistry.

[45]  K. Austen,et al.  Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. , 1992, The Journal of biological chemistry.

[46]  K. Austen,et al.  Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand , 1992, The Journal of experimental medicine.

[47]  R. Black,et al.  Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase , 1991, The Journal of experimental medicine.

[48]  M. Tsai,et al.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances. , 2005, Annual review of immunology.

[49]  A. Dvorak.  Subcellular localization of the cytokines, basic fibroblast growth factor and tumor necrosis factor-alpha in mast cells. , 2005, Chemical immunology and allergy.

[50]  M. Caligiuri,et al.  Interleukin 15: biology and relevance to human disease. , 2001, Blood.

[51]  H. Miller,et al.  Chapter 17 – Expression, Function and Regulation of Mast Cell Granule Chymases During Mucosal Allergic Responses , 2000 .